The spike protein found in SARS-CoV-2 contains a sequence identical to a genetic code linked to a piece of a gene patented by Moderna three years before the pandemic emerged, researchers found.
QUICK FACTS:
- An international team of researchers published a study in Frontiers in Virology, finding that the furin cleavage site (FCS) of SARS-CoV-2 holds a small amount of genetic code that replicates a part of a gene the pharmaceutical company Moderna patented in 2016.
- The researchers argue that because the chance of Moderna’s sequence randomly appearing naturally is 1 in 3 trillion, COVID may very well have been mutated in a lab experiment, InfoWars reported.
- “The presence in SARS-CoV-2 of a 19-nucleotide RNA sequence encoding an FCS at amino acid 681 of its spike protein with 100% identity to the reverse complement of a proprietary MSH3 mRNA sequence is highly unusual,” researchers said in the study.
